The stock market could face serious trouble in 2026 as extreme valuations collide with geopolitical tensions, AI investment skepticism, and policy headwinds. The Warren Buffett indicator has surged to about 220%, far above levels seen before past market declines, suggesting stocks may be detached from economic fundamentals, and that may be one of the major reasons Warren Buffett raised so much cash in Berkshire Hathaway. Meanwhile, the U.S.-Iran conflict is pushing oil prices higher and raising the risk of supply shocks and inflation. At the same time, massive AI spending by tech giants is fueling doubts about profitability, and with the top 10 stocks making up roughly 40% of major indices, any disappointment could trigger a rapid market correction. Toss in the fact that last week, BlackRock limited withdrawals from one of the private credit funds.
Investors seeking defensive companies that pay substantial dividends are drawn to the Dividend Aristocrats, and with good reason. The 69 companies that made the cut for the 2026 S&P 500 Dividend Aristocrats list have increased their dividends (not just maintained them) for 25 consecutive years. But the requirements go even further, with the following attributes also mandatory for membership on the aristocrats list:
- Companies must be worth at least $3 billion for each quarterly rebalancing.
- Their average daily volume must be at least $5 million transactions for every trailing three-month period at every quarterly rebalancing date.
- Each must be a member of the S&P 500.
We screened the 2026 list for the safest companies investors can buy now and hold for the rest of their lives. All are perfect ideas for worried investors who want to stay in the investing game while playing it as safely as possible. All five are rated Buy at the top Wall Street firms we cover.
Why do we cover the Dividend Aristocrats?
S&P 500 companies that have paid and raised their dividends for 25 years or longer are the types that growth and income investors want to buy and hold in their stock portfolios for the long term. These stocks are mostly conservative, and should we see a dramatic market correction, they will likely keep their ground much better than volatile technology names.
Abbott Laboratories
This healthcare giant announced a 6.8% dividend increase in December, marking the 54th consecutive year of dividend growth, and its dividend has risen more than 70% since 2020, currently standing at 2.10%. Abbott Laboratories (NYSE: ABT) is a global healthcare company. Its principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products.
Abbott Laboratories’ segments include:
- Established Pharmaceutical Products, which is engaged in the international sales of a broad line of branded generic pharmaceutical products.
- Diagnostic Products sells diagnostic systems and tests worldwide to blood banks, hospitals, commercial laboratories, and alternative-care testing sites.
- Nutritional Products is engaged in worldwide sales of a broad line of adult and pediatric nutritional products.
- Medical Devices is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
Barclays has an Overweight rating with a $142 target price.
Automatic Data Processing
This company, founded in 1949, is a global leader in payroll and HR services and provides cloud-based software trusted by over 80% of Fortune 100 companies. Automatic Data Processing (NYSE: ADP) is a global technology company engaged in providing cloud-based human capital management (HCM) solutions that unite HR, payroll, talent, time, tax, and benefits administration. The company benefits from its dominant position in payroll and HR services, with highly recurring, subscription-like revenue, and pays a 2.94% dividend.
Its segments include:
- Employer Services
- Professional Employer Organization (PEO)
The Employer Services segment serves clients ranging from single-employee small businesses to large enterprises with tens of thousands of employees worldwide, offering a range of technology-based HCM solutions, including its cloud-based platforms and human resource outsourcing (HRO) solutions (other than PEO).
The company’s offerings include:
- Payroll Services
- Benefits Administration
- Talent Management
- HR Management
- Workforce Management
- Compliance Services
- Insurance Services
- Retirement Services
Its PEO business, called ADP TotalSource, provides clients with employment administration outsourcing solutions. ADP serves over 1.1 million clients in 140 countries and territories.
Cantor Fitzgerald has a Buy rating with a $306 target price.
Coca-Cola
Coca-Cola (NYSE: KO) is an American multinational corporation founded in 1892. It remains a long-time top holding of Buffett and Berkshire Hathaway and pays a reliable 2.50% dividend. He owns a massive 400 million shares, which is 9.3% of the float and 9.9% of the portfolio.
Organic revenue rose 5% in 2025, and the company anticipates 4% to 5% growth in 2026, with analysts projecting adjusted EPS growth of 7% to 8%.
Coca-Cola is the world’s largest beverage company, offering consumers more than 500 sparkling and still brands, led by Coca-Cola, one of the world’s most valuable and recognizable brands. Its portfolio features 20 billion-dollar brands, including:
- Diet Coke
- Coca-Cola Light
- Coca-Cola Zero Sugar
- Caffeine-free Diet Coke
- Cherry Coke
- Fanta Orange
- Fanta Zero Orange
- Fanta Zero Sugar
- Fanta Apple
- Sprite
- Sprite Zero Sugar
- Simply Orange
- Simply Apple
- Simply Grapefruit
- Fresca
- Schweppes
- Dasani
- Fuze Tea
- Glacéau Smartwater
- Glacéau Vitaminwater
- Gold Peak
- Ice Dew
- Powerade
- Topo Chico
- Minute Maid
Globally, it is the top provider of sparkling beverages, ready-to-drink coffees, juices, and juice drinks. Through the world’s most extensive beverage distribution system, consumers in more than 200 countries enjoy the company’s beverages at a rate of over 1.9 billion servings per day.
It’s also important to remember that the company owns 16% of Monster Beverage (NASDAQ: MNST), which continues to deliver strong financial results.
Morgan Stanley has an Overweight rating and a target price of $87.
Johnson & Johnson
Johnson & Johnson (NYSE: JNJ) is a multinational American corporation specializing in pharmaceuticals, biotechnology, and medical devices. With shares trading at 14.5 times forward earnings and paying a 2.07% dividend, this diversified healthcare giant is a strong buy at current prices.
Johnson & Johnson is among the most conservative of the major pharmaceutical companies, with a diverse product portfolio and a familiar, solid brand. The company researches, develops, manufactures, and sells a range of healthcare products. Its primary focus is on products related to human health and well-being. It operates through two segments:
- Innovative Medicine
- MedTech
The Innovative Medicine segment is focused on various therapeutic areas, including:
- Immunology
- Infectious diseases
- Neuroscience
- Oncology
- Pulmonary hypertension
- Cardiovascular and metabolic diseases
Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
The MedTech segment encompasses a diverse portfolio of products used in orthopedics, surgery, interventional solutions, cardiovascular intervention, and vision care. It also offers a commercially available intravascular lithotripsy platform for the treatment of coronary artery disease and peripheral artery disease.
HSBC has a Buy rating with a $265 target price.
NextEra Energy
This is among the highest-rated utility stocks on Wall Street. NextEra Energy (NYSE: NEE) raised its quarterly dividend by 10% earlier this year and has previously committed to 10% annual dividend growth through this year, followed by 6% annual growth through 2028. The current dividend is 2.44%.
NextEra is an electric power and energy infrastructure company. It operates through its wholly owned subsidiaries, NextEra Energy Resources and NextEra Energy Transmission (collectively, NEER), and Florida Power & Light (FPL).
The FPL segment is a rate-regulated electric utility that generates, transmits, distributes, and sells electric energy in Florida. FPL has approximately 35,052 megawatts of net generating capacity, over 91,000 circuit miles of transmission and distribution lines, and 921 substations.
The NEER segment owns, develops, constructs, manages, and operates electric generation facilities in wholesale energy markets in the United States and Canada and includes assets and investments in other businesses with a clean energy focus, such as battery storage, natural gas pipelines, and renewable fuels. It owns, develops, constructs, and operates rate-regulated transmission facilities in North America.
The company is working with Google on developing gigawatt-scale data center campuses and will develop 2.5 GW of solar projects for Meta. NextEra also agreed to a 25-year deal with Alphabet to acquire 3 gigawatts of energy from a redeveloped nuclear facility.
UBS has a Buy rating, and its price target is $104.
Top Gaining Stocks
Top Losing Stocks